PhD Meeting Utrecht
Download as PPT, PDF1 like281 views
The document provides advice for career options after completing a PhD, including positions in academia such as postdoctoral research, or industry roles in pharmaceutical/biotech companies, government institutes, hospitals, medical writing, sales, and life science companies. It then outlines the author's specific career path, beginning with a postdoc position before becoming a product specialist and later product manager at a life science company, highlighting the rewarding and developmental aspects of those roles.
1 of 9
Download to read offline
Recommended
USG Science
USG ScienceUSGProfessionalsBelgium
油
USG Science Professionals deploys ambitious scientists on exciting projects. Our involvement allows companies to turn their challenges into practical solutions.
In R&D, production and distribution, our focus areas, we can support from A to Z. For both operational and strategic challenges, from advice to implementation. Our commitment to results is manifest in all our service models.
Heka company profile short 2021.5.may
Heka company profile short 2021.5.mayErkanMankan
油
HEKA was established in 2016 and combines 15 years of field experience in sales and marketing with a new philosophy. It offers a complete solution to customers in the pharmaceutical, chemical, and food sectors by combining science and technology. HEKA provides R&D consultancy, formulation services, analytical testing, and distribution support to partners in domestic and international markets. The company is dedicated to customer satisfaction through its team of experts and network of distributor partners.Heka company profile short 2021.5.may
Heka company profile short 2021.5.mayErkanMankan
油
HEKA is a science and technology company established in 2016 that offers complete solutions for the pharmaceutical, chemical, and food sectors. It combines research and development, formulation services in its lab, and sales, marketing, and after-sales support through domestic and international partners. HEKA's team has over 100 years of combined experience in fields like food engineering, business development, sales, and marketing. The company provides services such as R&D consultancy, formulation, analytical testing, distribution partnerships, and laboratory equipment and designs labs for industries and universities. HEKA currently has several ongoing projects focused on developing industrial production methods for active ingredients like curcumin and vitamins using techniques like nanoparticle engineering and liposomal delivery.Senior Biostatistician - Switzerland, Germany or UK
Senior Biostatistician - Switzerland, Germany or UKVania Macario
油
CTC Resourcing Solutions is a specialist staffing organization providing flexible resourcing to the pharmaceutical industry across Europe. They are currently looking for a Senior Biostatistician based in Switzerland, Germany, or the UK. The position involves leading statistical aspects of clinical trials including design, analysis, and results interpretation. Key responsibilities include ensuring quality and timeliness of deliverables, tracking milestones, adhering to regulations, and communicating results. Qualifications required include a university degree in mathematics, statistics, or related field, proven experience in all tasks of a trial statistician, experience with clinical research and regulations, proficiency in statistical software, strong communication and organizational skills, and fluency in English. The offer includes a competitive salary andAmbrosia Corporate Presentation
Ambrosia Corporate PresentationPriyanka_sakhardande123
油
Ambrosia Life Sciences is a visionary, end to end service provider for Pharmaceutical, Biotechnological, Medical Device and Consumer Heath Industries in the areas of Marketing, Research and Medical Services. We meet the needs of healthcare clients and providers through scientific expertise, excellence in delivery and limitless dedication that sets up apart from the rest.6. rijnierse.vbhc event prize - presentation amgen (def)
6. rijnierse.vbhc event prize - presentation amgen (def)Matthijs van Hagen
油
Amgen is the first and largest biotech company, established in 1980, that develops medicines for patients with high unmet medical needs. It has approximately 18,000 employees worldwide and is active in the US and 46 countries. Amgen's mission is to serve patients and its strategic priorities are centered around delivering patient value through outstanding performance, driving successful launches, and having an engaged and high performing organization. Amgen is working to fundamentally change how it operates in the healthcare landscape through value-based healthcare by collaborating with stakeholders and developing innovative pilots focused on optimizing patient flow, services, and outcomes.Career path en v03
Career path en v03jean-paul Richard
油
The document provides information about a 56-year-old man with 30 years of experience in the pharmaceutical industry. His career has involved roles in research and development, industrial production, and supply chain management. He has a background in chemistry and biochemistry and has worked to explore different areas of the pharmaceutical industry from drug synthesis to formulation to supply chain management. He is driven by leadership, team building, knowledge management, and driving projects to successful completion through questioning and improvement.Short summary Sven Engel, CEO SynapCon
Short summary Sven Engel, CEO SynapConSven Engel
油
Sven Engel has over 35 years of experience in clinical drug development and preclinical research. He has strong networks in the biotech and pharmaceutical industries in Germany, Austria, and Switzerland. As the CEO/COO of SynapCon, he provides expertise in clinical operations, project management, and experience with rare diseases and non-interventional studies. He has managed global projects and has extensive experience working with regulatory authorities and negotiating contracts with investigators.20180703 acell info_webinar
20180703 acell info_webinarDayOne
油
The document describes the DayOne Core Team, which consists of experts from various industries and stakeholders focused on improving children's health. The team includes representatives from pharmaceutical companies like Novartis and Idorsia, hospitals, universities, consultants, and government organizations. DayOne is an initiative managed by BaselArea.swiss in close collaboration with the Canton of Basel-Stadt to support healthcare innovation projects that can help solve health challenges for young people worldwide. Selected projects will receive up to 70,000 CHF in non-dilutive funding.Nibbelke cv
Nibbelke cvmnibbelke
油
Maarten Nibbelke is a MEDTECH executive with experience as a CEO and general manager. He has held senior roles at Baxter and helped grow revenues significantly as CEO of Polyganics. Currently he operates his own consulting business, 2MEDICAL-europe, and developed a medical device called ClearView Scopewarmer. He has over 25 years of experience in sales, marketing, operations and business development for medical devices and pharmaceutical companies.International marketing Marketing Decisions on marketing MIX
International marketing Marketing Decisions on marketing MIXDhanushka Bandara
油
This document provides information about Roche, a global healthcare company headquartered in Basel, Switzerland. Roche develops diagnostic tools and pharmaceuticals and has over 88,000 employees worldwide. It offers a wide range of products for research institutions, hospitals, commercial labs, physicians, and patients. Key products mentioned include ACTEMRA for rheumatoid arthritis and Accu-Chek systems for diabetes management. The document discusses Roche's global presence, pricing strategies, promotions, advertising, distribution channels, manufacturing processes, and evidence-based approach.DayOne background - digital nudges event
DayOne background - digital nudges eventDayOne
油
Presentation at DayOne Experts event on digital nudges and behavioral economics in healthcare in Basel 11 April 2018Biomedical engineering presentation
Biomedical engineering presentationcjaymarshall
油
The document provides information about Mikayla Jensen and her career in biomedical engineering. It discusses her educational background, including obtaining bachelor's and master's degrees in biomedical engineering. It outlines key aspects of biomedical engineering, such as taking life science and engineering courses. The document discusses career paths in industry and research, educational requirements, salaries that can be expected, typical work schedules, the job market, and some ethical issues involved in biomedical engineering research and industry.Biomedical engineering presentation
Biomedical engineering presentationcjaymarshall
油
The document provides information about Mikayla Jensen and her career in biomedical engineering. It discusses her educational background, including degrees in biomedical engineering and bioengineering. It describes biomedical engineering as the intersection of engineering and life sciences to develop new medical therapies. The document outlines typical coursework to prepare for the field as well as educational requirements, including prerequisites and core courses for bachelor's degrees. It also discusses career paths in industry and research, salaries, typical work schedules, the job market, and some ethical considerations within biomedical engineering. EuroBioForum 2013 - Day 2 | Frank Molina
EuroBioForum 2013 - Day 2 | Frank MolinaEuroBioForum
油
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# REGIONAL PERSPECTIVES #
EuroBioMed, France:
Private-public collaborations to boost open innovation
Dr Franck Molina
President of EDCA, Chair of diagnosis group of Eurobiomed
Director of Sysdiag
=======================================
http://www.eurobioforum.euCharles Jeffries CV2014
Charles Jeffries CV2014Charles Jeffries FRSA
油
Charles Jeffries is an experienced international management executive with over 30 years of experience leading operations in various industries. He has directly managed over 2000 employees across multiple international locations. Some of his accomplishments include establishing supply chain operations, successfully developing and launching new products, negotiating contracts, generating significant cost savings, and leading turnaround projects. He is currently a senior associate helping clients address business issues and strategy implementation.Biotechnology and Safety - RIVM Emerging Gene expression and Gene expression...
Biotechnology and Safety - RIVM Emerging Gene expression and Gene expression...Zhu Xiaoxi
油
This report summarizes emerging gene expression regulation technologies for medical applications. It finds that engineered nucleases like CRISPR/Cas9 can precisely modify genomes, epigenomes, and gene transcription. Small noncoding RNAs like miRNAs and siRNAs reveal new mechanisms to regulate genes and are investigated as therapeutics. Modified oligonucleotides can alter gene expression through mechanisms like miRNA inhibition and exon skipping. Many depend on delivery systems, with viral vectors commonly used but raising safety issues. While efficacy is shown, technical barriers remain. These technologies allow sustained gene regulation without changing genomes, circumventing some ethical concerns but raising others regarding transgenerational effects. Significant advances are expected with intensive ongoing research.cv business
cv businessklaas vandevyvere
油
This profile is for Klaas Vandevyvere, a 39-year-old Belgian physician and entrepreneur. He is the CEO and co-founder of M2M, a startup focused on improving patient experience and access to healthcare through digital technologies. As a physician, he believes in a proactive approach to healthcare and sees digitalization as enabling better patient-provider communication and personalized treatment. In his roles at AZ Groeninge hospital, he works to integrate new technologies and optimize clinical processes.One start finalists
One start finalistsjohndaley89
油
The document describes a team developing a technology to stabilize stem cells at room temperature, removing the need for freezing. The team includes Dr. Joanne Hackett, founder and CSO, with experience in regenerative medicine and business development, and Dr. Ryan MacDonald, project manager with a background in stem cell biology. The 贈100,000 investment would be used to protect intellectual property, undertake further studies, and provide seed funding to secure licensing deals and grants to further develop the technology.OneStart Top 10 Finalists
OneStart Top 10 Finalistsjohndaley89
油
The document describes a team developing a technology to stabilize stem cells at room temperature, removing the need for freezing. The team includes Dr. Joanne Hackett, founder and CSO, with experience in regenerative medicine and business development, and Dr. Ryan MacDonald, project manager with a background in stem cell biology. The 贈100,000 investment would be used to protect intellectual property, undertake further studies, and provide seed funding to secure licensing deals and grants to further develop the technology.Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...
Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...CTSI at UCSF
油
This presentation highlights how the UCSF Clinical and Translational Science Institute (CTSI) enhances and facilitates early-stage research efforts at UCSF and UCSF/industry partnerships - to develop new treatments, diagnostics and prevention.
Clinical Trial Supply Europe Conference
Clinical Trial Supply Europe ConferenceIQPC
油
Pharma IQ brings you Clinical Trial Supply Europe Conference Profit. Successfully cutting costs and overages whilst increasing the flexibility and reactivity of your clinical supply network to support global clinical trials.World ADC Frankfurt 2015 - sample brochure
World ADC Frankfurt 2015 - sample brochureWorld ADC
油
The World ADC Frankfurt meeting has been established with the simple mission of speeding up the development of more potent and safe antibody drug conjugates.
Learn not only how to make an ADC, but how to make a great one. With insights on numerous novel payload technologies, robust strategies for preclinical evaluation and emerging clinical data, there is no better opportunity to accelerate your research.Clinical Pharmacology Expert
Clinical Pharmacology ExpertVania Macario
油
CTC Resourcing Solutions is a specialist staffing organization based in Basel, London, and Munich providing flexible staffing to the pharmaceutical industry. They are currently looking for a Clinical Pharmacology Expert based in Basel, Switzerland to support oncology drug development. The position responsibilities include providing pharmacokinetic expertise, designing clinical pharmacology strategies, analyzing and reporting data, and ensuring collaboration within drug development teams. Qualifications include a Ph.D. in pharmacokinetics or related field with 6-10 years experience, expertise in related disciplines, experience using analysis tools, and strong communication and project management skills.CV-Englisch new
CV-Englisch newAnja-Natascha Straube
油
Dr. Anja-Natascha Straube is a medical doctor specializing in dermatology and allergology. She has over 20 years of experience working in dermatology clinics and the pharmaceutical industry. Currently, she is a Senior Medical Advisor at GSK focusing on vaccines including their Zoster vaccine. Her responsibilities include leading medical affairs activities in Europe and representing global medical affairs on zoster project teams. She provides medical and scientific support through activities such as training sales representatives, presenting data at conferences, and advising on study designs and materials.際際滷s Gateway2Germany - 28mei2009
際際滷s Gateway2Germany - 28mei2009Wouter de Heij
油
This document discusses food innovation and new combinations. It summarizes a presentation on this topic from May 28, 2009. The presentation covered several key points:
1) Innovation in the food industry is shifting from prefabricated and standardized products to those that are more customized, authentic, and focus on health and pleasure.
2) The Dutch government has programs to support food innovation, including research funding and subsidies for small businesses. Innovation projects involve areas like food design, process development, and management support.
3) Partnerships are important for innovation between universities, knowledge institutes, technology suppliers, food companies, and other organizations in the food chain. There must be a clear business case and agreement on intellectual property and2nd European Conference on Clinical Research
2nd European Conference on Clinical ResearchMarket iT
油
The document provides information on the organizers, program committee, and agenda for the 2nd European Conference on Clinical Research being held from February 2-4, 2015 in Paris, France. The pre-conference on February 2nd will focus on how clinical procurement can provide strategic value beyond cost reductions. The main conference on February 3rd-4th will involve presentations and debates on key issues in clinical research regulation, new technologies, risk management, and the patient's role. Topics will include the impacts and challenges of the new EU Clinical Trials Regulation and new operational practices in clinical trials.WakeUp251111_Case_Mendor
WakeUp251111_Case_MendorSpinno Enterprise Center
油
Mendor aims to become a leader in blood glucose monitoring and management. It has developed an all-in-one discreet blood glucose meter and online analysis software. The company was founded in 2006 in Finland and has since raised over 13 million. It now has sales partnerships in multiple countries and regions. Mendor believes in user-centric design and a fun company culture to attract top talent.
More Related Content
Similar to PhD Meeting Utrecht (20)
20180703 acell info_webinar
20180703 acell info_webinarDayOne
油
The document describes the DayOne Core Team, which consists of experts from various industries and stakeholders focused on improving children's health. The team includes representatives from pharmaceutical companies like Novartis and Idorsia, hospitals, universities, consultants, and government organizations. DayOne is an initiative managed by BaselArea.swiss in close collaboration with the Canton of Basel-Stadt to support healthcare innovation projects that can help solve health challenges for young people worldwide. Selected projects will receive up to 70,000 CHF in non-dilutive funding.Nibbelke cv
Nibbelke cvmnibbelke
油
Maarten Nibbelke is a MEDTECH executive with experience as a CEO and general manager. He has held senior roles at Baxter and helped grow revenues significantly as CEO of Polyganics. Currently he operates his own consulting business, 2MEDICAL-europe, and developed a medical device called ClearView Scopewarmer. He has over 25 years of experience in sales, marketing, operations and business development for medical devices and pharmaceutical companies.International marketing Marketing Decisions on marketing MIX
International marketing Marketing Decisions on marketing MIXDhanushka Bandara
油
This document provides information about Roche, a global healthcare company headquartered in Basel, Switzerland. Roche develops diagnostic tools and pharmaceuticals and has over 88,000 employees worldwide. It offers a wide range of products for research institutions, hospitals, commercial labs, physicians, and patients. Key products mentioned include ACTEMRA for rheumatoid arthritis and Accu-Chek systems for diabetes management. The document discusses Roche's global presence, pricing strategies, promotions, advertising, distribution channels, manufacturing processes, and evidence-based approach.DayOne background - digital nudges event
DayOne background - digital nudges eventDayOne
油
Presentation at DayOne Experts event on digital nudges and behavioral economics in healthcare in Basel 11 April 2018Biomedical engineering presentation
Biomedical engineering presentationcjaymarshall
油
The document provides information about Mikayla Jensen and her career in biomedical engineering. It discusses her educational background, including obtaining bachelor's and master's degrees in biomedical engineering. It outlines key aspects of biomedical engineering, such as taking life science and engineering courses. The document discusses career paths in industry and research, educational requirements, salaries that can be expected, typical work schedules, the job market, and some ethical issues involved in biomedical engineering research and industry.Biomedical engineering presentation
Biomedical engineering presentationcjaymarshall
油
The document provides information about Mikayla Jensen and her career in biomedical engineering. It discusses her educational background, including degrees in biomedical engineering and bioengineering. It describes biomedical engineering as the intersection of engineering and life sciences to develop new medical therapies. The document outlines typical coursework to prepare for the field as well as educational requirements, including prerequisites and core courses for bachelor's degrees. It also discusses career paths in industry and research, salaries, typical work schedules, the job market, and some ethical considerations within biomedical engineering. EuroBioForum 2013 - Day 2 | Frank Molina
EuroBioForum 2013 - Day 2 | Frank MolinaEuroBioForum
油
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# REGIONAL PERSPECTIVES #
EuroBioMed, France:
Private-public collaborations to boost open innovation
Dr Franck Molina
President of EDCA, Chair of diagnosis group of Eurobiomed
Director of Sysdiag
=======================================
http://www.eurobioforum.euCharles Jeffries CV2014
Charles Jeffries CV2014Charles Jeffries FRSA
油
Charles Jeffries is an experienced international management executive with over 30 years of experience leading operations in various industries. He has directly managed over 2000 employees across multiple international locations. Some of his accomplishments include establishing supply chain operations, successfully developing and launching new products, negotiating contracts, generating significant cost savings, and leading turnaround projects. He is currently a senior associate helping clients address business issues and strategy implementation.Biotechnology and Safety - RIVM Emerging Gene expression and Gene expression...
Biotechnology and Safety - RIVM Emerging Gene expression and Gene expression...Zhu Xiaoxi
油
This report summarizes emerging gene expression regulation technologies for medical applications. It finds that engineered nucleases like CRISPR/Cas9 can precisely modify genomes, epigenomes, and gene transcription. Small noncoding RNAs like miRNAs and siRNAs reveal new mechanisms to regulate genes and are investigated as therapeutics. Modified oligonucleotides can alter gene expression through mechanisms like miRNA inhibition and exon skipping. Many depend on delivery systems, with viral vectors commonly used but raising safety issues. While efficacy is shown, technical barriers remain. These technologies allow sustained gene regulation without changing genomes, circumventing some ethical concerns but raising others regarding transgenerational effects. Significant advances are expected with intensive ongoing research.cv business
cv businessklaas vandevyvere
油
This profile is for Klaas Vandevyvere, a 39-year-old Belgian physician and entrepreneur. He is the CEO and co-founder of M2M, a startup focused on improving patient experience and access to healthcare through digital technologies. As a physician, he believes in a proactive approach to healthcare and sees digitalization as enabling better patient-provider communication and personalized treatment. In his roles at AZ Groeninge hospital, he works to integrate new technologies and optimize clinical processes.One start finalists
One start finalistsjohndaley89
油
The document describes a team developing a technology to stabilize stem cells at room temperature, removing the need for freezing. The team includes Dr. Joanne Hackett, founder and CSO, with experience in regenerative medicine and business development, and Dr. Ryan MacDonald, project manager with a background in stem cell biology. The 贈100,000 investment would be used to protect intellectual property, undertake further studies, and provide seed funding to secure licensing deals and grants to further develop the technology.OneStart Top 10 Finalists
OneStart Top 10 Finalistsjohndaley89
油
The document describes a team developing a technology to stabilize stem cells at room temperature, removing the need for freezing. The team includes Dr. Joanne Hackett, founder and CSO, with experience in regenerative medicine and business development, and Dr. Ryan MacDonald, project manager with a background in stem cell biology. The 贈100,000 investment would be used to protect intellectual property, undertake further studies, and provide seed funding to secure licensing deals and grants to further develop the technology.Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...
Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...CTSI at UCSF
油
This presentation highlights how the UCSF Clinical and Translational Science Institute (CTSI) enhances and facilitates early-stage research efforts at UCSF and UCSF/industry partnerships - to develop new treatments, diagnostics and prevention.
Clinical Trial Supply Europe Conference
Clinical Trial Supply Europe ConferenceIQPC
油
Pharma IQ brings you Clinical Trial Supply Europe Conference Profit. Successfully cutting costs and overages whilst increasing the flexibility and reactivity of your clinical supply network to support global clinical trials.World ADC Frankfurt 2015 - sample brochure
World ADC Frankfurt 2015 - sample brochureWorld ADC
油
The World ADC Frankfurt meeting has been established with the simple mission of speeding up the development of more potent and safe antibody drug conjugates.
Learn not only how to make an ADC, but how to make a great one. With insights on numerous novel payload technologies, robust strategies for preclinical evaluation and emerging clinical data, there is no better opportunity to accelerate your research.Clinical Pharmacology Expert
Clinical Pharmacology ExpertVania Macario
油
CTC Resourcing Solutions is a specialist staffing organization based in Basel, London, and Munich providing flexible staffing to the pharmaceutical industry. They are currently looking for a Clinical Pharmacology Expert based in Basel, Switzerland to support oncology drug development. The position responsibilities include providing pharmacokinetic expertise, designing clinical pharmacology strategies, analyzing and reporting data, and ensuring collaboration within drug development teams. Qualifications include a Ph.D. in pharmacokinetics or related field with 6-10 years experience, expertise in related disciplines, experience using analysis tools, and strong communication and project management skills.CV-Englisch new
CV-Englisch newAnja-Natascha Straube
油
Dr. Anja-Natascha Straube is a medical doctor specializing in dermatology and allergology. She has over 20 years of experience working in dermatology clinics and the pharmaceutical industry. Currently, she is a Senior Medical Advisor at GSK focusing on vaccines including their Zoster vaccine. Her responsibilities include leading medical affairs activities in Europe and representing global medical affairs on zoster project teams. She provides medical and scientific support through activities such as training sales representatives, presenting data at conferences, and advising on study designs and materials.際際滷s Gateway2Germany - 28mei2009
際際滷s Gateway2Germany - 28mei2009Wouter de Heij
油
This document discusses food innovation and new combinations. It summarizes a presentation on this topic from May 28, 2009. The presentation covered several key points:
1) Innovation in the food industry is shifting from prefabricated and standardized products to those that are more customized, authentic, and focus on health and pleasure.
2) The Dutch government has programs to support food innovation, including research funding and subsidies for small businesses. Innovation projects involve areas like food design, process development, and management support.
3) Partnerships are important for innovation between universities, knowledge institutes, technology suppliers, food companies, and other organizations in the food chain. There must be a clear business case and agreement on intellectual property and2nd European Conference on Clinical Research
2nd European Conference on Clinical ResearchMarket iT
油
The document provides information on the organizers, program committee, and agenda for the 2nd European Conference on Clinical Research being held from February 2-4, 2015 in Paris, France. The pre-conference on February 2nd will focus on how clinical procurement can provide strategic value beyond cost reductions. The main conference on February 3rd-4th will involve presentations and debates on key issues in clinical research regulation, new technologies, risk management, and the patient's role. Topics will include the impacts and challenges of the new EU Clinical Trials Regulation and new operational practices in clinical trials.WakeUp251111_Case_Mendor
WakeUp251111_Case_MendorSpinno Enterprise Center
油
Mendor aims to become a leader in blood glucose monitoring and management. It has developed an all-in-one discreet blood glucose meter and online analysis software. The company was founded in 2006 in Finland and has since raised over 13 million. It now has sales partnerships in multiple countries and regions. Mendor believes in user-centric design and a fun company culture to attract top talent.More from michielvds (9)
PhD thesis 2004
PhD thesis 2004michielvds
油
This document describes a doctoral thesis that investigates the regulation of apoptosis induced by inhibition of phosphatidylcholine synthesis. The thesis was presented by Michiel Henrik Marie van der Sanden to obtain a doctoral degree from Utrecht University. It includes chapters that examine how inhibition of phosphatidylcholine synthesis affects cellular morphology, lipid composition, and generation of lipid droplets. It also analyzes the induction of endoplasmic reticulum stress and apoptosis-related proteins, such as C/EBP-Homologous Protein, during inhibition of phosphatidylcholine synthesis.GCP certificate
GCP certificatemichielvds
油
This certificate certifies that Michiel van der Sanden of Eurofins Medinet successfully passed a web-based examination on the International Conference on Harmonisation - Good Clinical Practice Guideline Course. The certificate is endorsed by the Course Director and Professor and Head of the School of Biological Sciences at Royal Holloway, University of London.Technical support training cell signaling
Technical support training cell signalingmichielvds
油
The document discusses technical training on signal transduction and CST products. It describes kinases and their role in phosphorylating effectors, and the use of phosphospecific antibodies, siRNA kits, and kinases/kinase assays. Application of phosphospecific and total antibodies are summarized for techniques like western blotting, immunohistochemistry, immunofluorescence, flow cytometry, immunoprecipitation, in cell western, and ELISA. Protocols are provided for some of these techniques.Cyto gi ingekort
Cyto gi ingekortmichielvds
油
This document discusses the use of activation-state specific antibodies for analyzing cellular signaling using imaging cytometry techniques like immunofluorescence and high content analysis. It provides examples of how these antibodies can be used to study phosphorylation events, apoptosis, and validate optimal antibody concentrations. The document also discusses the potential for using these antibodies in flow cytometry applications like clinical assays to study disease signaling pathways.Ortho biotech 04 aug-081
Ortho biotech 04 aug-081michielvds
油
This document provides an overview of Eurofins Medinet, a central laboratory services provider. It details Eurofins' global network of laboratories and key services, including central laboratory services, bioanalysis, biomarkers, and specialized testing. Eurofins offers a full range of analytical testing services to support pharmaceutical and biotech drug development.
Cyto gi bioke4
Cyto gi bioke4michielvds
油
This document discusses the analysis of cellular signaling using activation-state specific antibodies. It begins by describing different types of activation-state specific antibodies, such as phospho-specific, cleavage-specific, and motif-specific antibodies. It then discusses techniques for validating and applying these antibodies for imaging cytometry and high content analysis, including immunofluorescence, antibody titration, and conjugation to fluorescent dyes. Finally, it covers protocols and applications for using activation-state specific antibodies in flow cytometry, including clinical assays for diseases like chronic myelogenous leukemia and chronic lymphocytic leukemia.PhD Meeting Utrecht
- 1. Help, I finished my PhD! What to do after your promotion? Product Specialist / Product Manager Life Sciences Michiel van der Sanden, PhD
- 2. Master graduate student at the faculty of Biology, UU - Department of Endocrinology, UU - Hubrecht Laboratorium, Utrecht PhD thesis at the department Biochemistry and Cell Biology of the faculty Veterinary Medecine, UU Regulation of Apoptosis, induced by PC synthesis inhibition Education
- 3. Post-doc position (Netherlands or abroad) R&D Scientist in pharmaceutical or biotechnical company (Organon, DSM, Janssen Pharma, Philips, Crucell) Scientist at governmental institute (TNO, RIVM, NFI) Clinical Chemist/Geneticist in Education (all hospitals) Medical Writer (pharmaceutical companies or institutes) Medical Representative at a pharmaceutical company Account Manager at a Life Science company (BIOK, Sigma, Invitrogen, BD) Product Specialist/Technical Support at Life Science company Help, I finished my PhD! What now?
- 4. Decision made to leave academic world: - Small change on getting a fixed position - Too less effect of my work Post-doc at German Cancer Institute DKFZ Pathway Profiling of Squamous Cell Carcinomas
- 5. R&D Scientist in pharmaceutical or biotechnical company (Organon, DSM, Janssen Pharma, Philips, Crucell) Scientist at governmental institute (TNO, RIVM, NFI) Clinical Chemist/Geneticist in Education (all hospitals) Medical Writer (pharmaceutical companies or institutes) Medical Representative at a pharmaceutical company Account Manager at a Life Science company (BIOK, Sigma, Invitrogen, BD) Product Specialist / Technical Support at BIOK Help, I want to switch! What now?
- 6. Product Specialist / Technical Support Technical support to customers for different product lines of BIOK (molecular biology and celbiology; CST,Idaho, FZ, etc) Pilot trials for new technologies for customers (CST/Idaho) Support Marketing Support Account Managers Interesting aspects of the job: Very rewarding (problem solving) Learning new, innovative techniques and applications Developping yourself on other fields (Sales, Marketing, Project Management
- 7. Product Manager Cell Signaling Technology (CST) End-Responsable for policy CST Business Development in Benelux for CST Organising scientific symposia in the Netherlands and Belgium Lead Marketing team for CST Lead Sales team CST and participate active in Sales Technical support for CST customers Interesting aspects of the job: Very rewarding (grow of the company / succesfull symposia) Making a broad network through the Benelux Developping yourself on other fields (leadership, project management, public relations)
- 8. Signal Transduction symposium on March 18th in Jaarbeurs Utrecht Randy Wetzel, PhD, CST USA Clemens L旦wik, PhD, Endocrinology, LUMC Rob Ruijtenbeek, PhD, Pamgene International Anton Koning, PhD, Bio-informatics, Erasmus Jeroen den Hertog, PhD, Hubrecht Laboratory Symposia are always great places to orientate yourself for the future and getting to know people
- 9. It is important what you know, but it is even more important who you know